First Solar 10-Qquarter ended 2026-06-30

Executive Summary

First Solar sells cadmium-telluride solar modules primarily to U.S. project developers and system operators, with India its main other market. It is expanding U.S. manufacturing and upgrading module technology to compete through localized production rather than Chinese crystalline-silicon supply chains. Q2 earnings improved despite lower revenue, but manufacturing incentives and an $88.6M tariff-refund benefit explain much of the margin strength. Contracted future sales of $13.6B provide visibility through 2030, although cancellations, policy changes and global oversupply threaten that opportunity. Investors need to distinguish sustainable manufacturing improvements from policy-dependent earnings while watching whether profits translate into cash.

What's Happening in the Business

• Demand and sales mix: Higher module shipments supported H1 growth, but a greater India sales mix reduced revenue per watt. Q2 revenue fell because lower customer contract-termination revenue more than offset higher third-party module sales volume; the decline therefore does not indicate falling shipments.
• Manufacturing footprint: The fifth U.S. factory recently began operations. Management expects phase one of the sixth facility, in South Carolina, to start in H2 2026, with ≈$300M of investment to bring final production processes onshore. Meanwhile, First Solar reduced international Series 6 production because of low-priced Chinese competition, regional oversupply and trade barriers.
• Technology investment: An Ohio facility converted to CuRe technology during H1, with further deployment planned. A perovskite pilot line is expected in 2027; these programs, alongside bifacial-module development, support differentiation but require spending before commercial returns are established.
• Trade-policy reversal: Following the Supreme Court’s 2/20/2026 ruling against emergency-powers tariffs, First Solar filed refund claims and began receiving payments. Subsequent tariffs create new costs, so refunds do not represent a permanent reduction in trade exposure.

Key Financial Highlights

• Earnings quality: Q2 gross margin reached 57.3%, from 45.6%. Government grant benefits recognized as cost reductions totaled $444M, largely in cost of sales; tariff refunds provided a separate, nonrecurring benefit. Underlying manufacturing progress should not be confused with these policy-linked gains.
• Profit versus cash: Against H1 net income shown above, grants receivable increased $649M and inventory increased $306M—earnings were recognized before the related cash arrived, while inventory required funding. After $280M of capital expenditure, FCF was $(640)M.
• Liquidity and investment: Cash and cash equivalents fell to $1.69B from $2.80B at year-end, alongside substantial debt repayment. Debt principal fell to $37.6M from $499M; a new $1.5B revolving credit facility adds flexibility. Management expects FY2026 capital expenditure of $800M–$1.0B, implying heavier investment in H2.

Risk Assessment

• Policy-dependent economics: Manufacturing incentives materially support margins and funding, while accelerated solar-credit phaseouts and eligibility restrictions could weaken both customer demand and factory economics.
• Trade and international utilization: New tariffs, Chinese oversupply and potential Indian efficiency requirements could restrict sales or force further international production cuts, closures or asset impairments.
• Contract durability: The 45.1-gigawatt backlog is not guaranteed; customer amendments, domestic-content requirements and delivery delays can cause cancellations, deposit returns or damages.
• Series 7 quality: Premature power loss in certain 2023–2024 modules carries a $47M specific warranty liability against estimated potential losses of $40M–$65M, exposing First Solar to remediation costs and reputational damage.
• Cash timing and commitments: Growing grant receivables and inventory compete with expansion spending, while substrate-glass contracts carry termination payments of up to ≈$300M.
• Technology and supply protection: China’s tellurium export controls threaten a key manufacturing input, while uncertain TOPCon patent disputes require uninsured legal spending and could weaken intellectual-property protection.

This 10-Q lists only the risk factors that changed since the annual report. Full list: the company's 10-Ks on SEC.

What to Watch

• U.S. expansion: Management targets South Carolina’s first phase for H2 2026. Timely production and controlled start-up costs would validate localization; delays or persistent ramp costs would weaken its economics.
• Backlog conversion: Contracted deliveries extend through 2030, but termination revenue already affects comparisons. Deliveries without cancellations or price concessions would support visibility; amendments and deposit returns would undermine it.
• Series 7 field performance: The existing reserve covers a defined module population. Stable claims and successful remediation would contain the problem; broader failures or reserve increases would challenge product economics.
• Cash recovery: Grant receivables and inventory drove H1 cash absorption. Collections and inventory conversion would fund expansion internally; continued outflows would increase reliance on existing liquidity and credit facilities.